ACERTA PHARMA

Updated 14 days ago
  • ID: 21177828/65
Acerta Pharma is a leader in the field of covalent binding technology and is applying this technology to create novel, highly selective therapies for cancer. In February 2016, AstraZeneca acquired a majority share of Acerta Pharma via a USD $4 billion investment and is a committed partner to the development of these innovative drugs.
Also known as: Acerta Pharma B.V.
  • 0
  • 0
Interest Score
9
HIT Score
0.98
Domain
acerta-pharma.com

Actual
www.acerta-pharma.com

IP
52.85.92.13, 52.85.92.26, 52.85.92.54, 52.85.92.123

Status
OK

Category
Company
0 comments Add a comment